
Senior Director, Pfizer
New London/Norwich, Connecticut Area

Senior Director, Pfizer
New London/Norwich, Connecticut Area
Chris L. Waller, Ph.D. is the Senior Director of Precompetitive Collaborations in Worldwide Technology at Pfizer, Inc., where his interest is in the development of collaborations between pharmaceutical, biotechnology, technology, academic, and government organizations to develop and promote the use of standards, identify partnerships, and transfer technology in order to drive greater process efficiency and lower costs. Waller has a Doctorate in Medicinal Chemistry and Natural Products from the University of North Carolina-Chapel Hill and a Bachelors of Science in Pre-medical Studies from Davidson College.
In his current role, Waller is spearheading a new initiative within Pfizer that consists of three primary elements: (1) the definition and promotion of industry standards (e.g., data models, APIs, processes, etc.) across the Research and Development and Medical continuum through participation on various cross-pharmaceutical company entities (e.g., Waller is a Senior Core Member of the Pistoia Alliance, Inc.); (2) proactive pursuit of pre/non-competitive collaborative application or technology development opportunities (e.g., industry partnerships focused on the development of commodity applications or services); and (3) identification and cultivation of opportunities to generate revenue by monetizing Pfizer’s portfolio of products and services (e.g., divestment and/or licensing of Pfizer-developed applications).
He was previously Worldwide Head of Chemistry Informatics at Pfizer where he was responsible for the strategic direction of the IT portfolio of products and services in support of enterprise chemical and biological data access and analysis as well as medicinal chemistry compound design and synthesis. Prior to joining Pfizer, Waller held various positions at Eli Lilly and Company (Sphinx Laboratories), OSI Pharmaceuticals, Inc. and the U.S. Environmental Protection Agency.
technology assessment, vendor negotiation, drug discovery, laboratory automation, robotics, informatics systems, technology transfer, academic relationships
(Public Company; PFE; Pharmaceuticals industry)
January 2009 — Present (11 months)
Develop collaborations between pharmaceutical, biotechnology, technology, academic, and government organizations in precompetitive space to develop and promote the use of standards, identify partnerships, and transfer technology in order to drive greater process efficiency and lower costs.
(Public Company; PFE; Pharmaceuticals industry)
December 2005 — December 2008 (3 years 1 month)
(Public Company; 10,001 or more employees; PFE; Pharmaceuticals industry)
November 2001 — November 2005 (4 years 1 month)
(Information Technology and Services industry)
1999 — 2001 (2 years )
(Pharmaceuticals industry)
1995 — 1999 (4 years )
Ph.D. , Medicinal Chemistry , 1988 — 1992
B.S. , Premedicine , 1983 — 1987
American Chemical Society
Distinguished Alumnus Award, School of Pharmacy, University of North Carolina at Chapel Hill, 2006.
Scientific and Technical Achievement Award, United States Environmental Protection Agency, 1997.
Best Paper in Toxicology and Applied Pharmacology Award, Society of Toxicology, 1996.
Special Act Award, Presentation of Endocrine Disruptor Research Efforts to Fred Hansen, Deputy Director, EPA, 1995.
Special Act Award, Development of QSAR Models for Endocrine Disruptors, EPA, 1995.
Ruth and Vernon Taylor Scholarship, Davidson College, 1986-1987.
Alumni Honor Scholarship, Davidson College, 1983-1986.